Water Island Capital’s Trillium Therapeutics Inc. TRIL Stock Holding History

Water Island Capital’s Portfolio TRIL Stock Details TRIL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-273,200	Closed	-$7K	–	118
2021 Q3	$7K	Buy	+273,200	New	+$3.19M	﹤0.01%	70

Other funds holding TRIL

Optiver Holding Amsterdam, Netherlands $289B AUM 33.63% 1-Year Est. Return

Water Island Capital's TRIL Position: Q4 2021 in Review

Water Island Capital sold out of Trillium Therapeutics Inc. (TRIL) in Q4 2021, closing a stake of 423,290 shares — an estimated $7.43M sold.

Water Island Capital first reported a position in TRIL in Q3 2021 and held it in 1 quarter. The position peaked at $7.43M in Q3 2021. 2 funds tracked by Wall St. Rank hold TRIL as of Q4 2021.

Water Island Capital reported no remaining Trillium Therapeutics Inc. position as of Q4 2021 after selling out during the quarter.
Water Island Capital sold 423,290 Trillium Therapeutics Inc. shares in Q4 2021, an estimated $7.43M.
Water Island Capital first reported a position in Trillium Therapeutics Inc. in Q3 2021 and held it in 1 quarter.
Water Island Capital's Trillium Therapeutics Inc. position peaked at $7.43M in Q3 2021.
2 funds tracked by Wall St. Rank held Trillium Therapeutics Inc. as of Q4 2021.

Based on Water Island Capital's 13F filing for Q4 2021, filed 14 Feb 2022.